Most children recover from COVID-19 within a few weeks, returning to school, sports, and their usual routines with few lingering effects. Yet for a subset of pediatric patients, recovery is incomplete. Weeks or months after the initial infection, they continue to experience profound fatigue, headaches, dizziness, cognitive difficulties, exercise intolerance, sleep disturbances, gastrointestinal symptoms, or diffuse pain that interfere with daily functioning. These children often undergo extensive evaluations that reveal few objective abnormalities, leaving families frustrated and clinicians searching for answers.
Long COVID, also referred to as post-COVID condition (PCC) or post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as one of the most complex pediatric conditions of the post-pandemic era. Fortunately, our understanding has advanced considerably over the past several years. Rather than representing a single disease process, Long COVID appears to be a multifactorial syndrome involving dysregulation across multiple physiologic systems. For pediatricians—particularly those practicing integrative medicine—this systems-based perspective provides a useful framework for both evaluation and management.
Recognizing Long COVID in Clinical Practice
Current pediatric definitions generally describe Long COVID as symptoms that persist for at least three months following confirmed or probable SARS-CoV-2 infection and cannot be explained by an alternative diagnosis. The presentation is remarkably heterogeneous. Fatigue remains the most common complaint, but many children also report “brain fog,” headaches, dizziness, sleep disturbances, abdominal pain, palpitations, shortness of breath, anosmia, anxiety, depression, and generalized musculoskeletal pain. Importantly, symptom severity often fluctuates, with periods of relative improvement followed by unexpected setbacks.
One of the most important clinical pearls emerging from recent pediatric guidance is that post-exertional malaise (PEM) should be actively assessed. Unlike ordinary fatigue, PEM describes a worsening of symptoms hours to days after physical, cognitive, or emotional exertion. Children may initially tolerate an activity only to “crash” 24 to 48 hours later, requiring prolonged recovery. Recognizing PEM is essential because it fundamentally changes management. Traditional graded exercise programs, once recommended for chronic fatigue syndromes, may actually worsen symptoms in patients experiencing post-exertional malaise. Instead, pacing and energy conservation have become central components of management.
Clinicians should also remember that not every child with persistent symptoms after COVID has Long COVID. Recent pediatric reviews note that comprehensive evaluation frequently identifies alternative diagnoses, including endocrine disorders, anemia, autoimmune disease, primary sleep disorders, migraine, dysautonomia unrelated to COVID, or psychiatric conditions. Maintaining a broad differential diagnosis remains essential before attributing symptoms solely to Long COVID.
Understanding the Biology: More Than Persistent Viral Infection
Although many questions remain unanswered, the emerging science suggests that Long COVID is driven by several overlapping biologic mechanisms rather than a single cause. Proposed contributors include persistent immune activation, viral persistence, mitochondrial dysfunction, endothelial injury, autonomic nervous system dysfunction, chronic inflammation, autoimmunity, and alterations in the gut microbiome. These mechanisms likely vary from one patient to another, explaining the broad range of clinical presentations.
Mitochondrial dysfunction has received increasing attention because it provides a plausible explanation for many hallmark symptoms, including fatigue, exercise intolerance, muscle weakness, and cognitive slowing. Similarly, endothelial dysfunction may impair microvascular blood flow and oxygen delivery, while chronic neuroinflammation appears to contribute to cognitive impairment and “brain fog.” Dysautonomia, including postural orthostatic tachycardia syndrome (POTS), has also been increasingly recognized in adolescents with persistent dizziness, tachycardia, and exercise intolerance following COVID-19 infection.
This multifactorial model aligns well with an integrative approach to medicine. Rather than searching for a single therapeutic target, clinicians may need to support multiple physiologic systems simultaneously as the body gradually restores homeostasis.
Current Evidence-Based Management
Because no curative therapy currently exists, treatment remains individualized and symptom-directed. Recent pediatric reviews consistently emphasize that multidisciplinary care offers the greatest opportunity for recovery. Depending on the child’s symptom profile, this may include primary care, pediatric subspecialists, physical and occupational therapists, psychologists, rehabilitation specialists, and school personnel working together to develop realistic treatment goals.
Several interventions have become foundational:
- Careful pacing and energy conservation, particularly for children with post-exertional malaise.
- Optimization of sleep hygiene and treatment of sleep disorders.
- Adequate hydration, increased sodium intake when appropriate, compression garments, and medications for patients with dysautonomia or POTS.
- Gradual return to school with individualized accommodations.
- Physical and occupational therapy tailored to symptom tolerance rather than aggressive conditioning.
- Cognitive rehabilitation for persistent brain fog.
- Psychological support to improve coping, reduce anxiety, and address the emotional burden of chronic illness.
Importantly, psychological support should not be interpreted as evidence that Long COVID is “all in the child’s head.” Rather, current pediatric guidance emphasizes that physical illness and psychological distress frequently coexist. Living with a poorly understood chronic illness understandably increases anxiety, depression, frustration, and social isolation. Supporting mental health while simultaneously validating the physiologic reality of Long COVID represents compassionate, evidence-based care.
Where Does Integrative Medicine Fit?
For pediatricians practicing integrative medicine, Long COVID presents both opportunities and challenges. Many proposed interventions have biologic plausibility, yet pediatric evidence remains limited. Families should understand that most recommendations beyond supportive care are extrapolated from adult studies or based on preliminary research.
Lifestyle interventions remain the foundation of care. Anti-inflammatory nutrition, correction of micronutrient deficiencies, restorative sleep, stress reduction, autonomic regulation, and carefully paced physical activity all support the physiologic systems thought to be disrupted in Long COVID. Breathing exercises, mindfulness practices, yoga, and relaxation techniques may also improve autonomic balance, reduce symptom burden, and enhance coping, although high-quality pediatric trials remain limited.
Several nutraceuticals have attracted growing interest because of their potential effects on mitochondrial function, oxidative stress, endothelial health, or immune regulation. Coenzyme Q10 and alpha-lipoic acid have been studied for their ability to support mitochondrial energy production and reduce fatigue. N-acetylcysteine (NAC) may replenish intracellular glutathione and reduce oxidative stress, while omega-3 fatty acids offer anti-inflammatory effects and may improve endothelial function. L-arginine, often combined with vitamin C, has demonstrated encouraging improvements in fatigue and dyspnea in observational studies through enhanced nitric oxide production and vascular function. Vitamin D and melatonin have also been proposed as adjunctive therapies because of their immunomodulatory, anti-inflammatory, and circadian effects, although clinical evidence remains preliminary.
Low-dose naltrexone (LDN) has generated particular interest among integrative clinicians. Several observational studies have demonstrated improvements in fatigue, post-exertional malaise, sleep quality, pain, and cognitive symptoms. Proposed mechanisms include modulation of neuroinflammation and normalization of immune signaling. Although these early findings are encouraging, randomized pediatric trials have not yet been completed.
Among pharmacologic therapies, metformin currently has the strongest evidence, although its role is preventive rather than therapeutic. Two large randomized Phase III trials demonstrated that initiating metformin during acute COVID-19 infection reduced the subsequent development of Long COVID by approximately 40–60%, with the greatest benefit seen when treatment began within the first few days of illness. Whether metformin benefits children with established Long COVID remains unknown.
Other therapies—including intravenous immunoglobulin (IVIG), dexamethasone, therapeutic apheresis, guanfacine combined with NAC for cognitive symptoms, and statins targeting endothelial dysfunction—remain investigational. While some have shown encouraging results in small studies, the current evidence is insufficient to support routine pediatric use outside carefully selected clinical circumstances.
Addressing the Emotional Dimension Without Dismissing the Biology
One of the most thoughtful aspects of the recent pediatric literature is its balanced discussion of emotional health. The pandemic itself increased rates of anxiety, depression, loneliness, disrupted schooling, and social isolation among children, regardless of infection status. These factors may amplify symptom perception, complicate recovery, or coexist with Long COVID, but they should never be used to dismiss persistent physical symptoms.
Instead, clinicians should adopt a trauma-informed, biopsychosocial approach. Validating the child’s experience while simultaneously exploring emotional stressors, family dynamics, sleep quality, school challenges, and coping strategies allows for truly whole-person care. Mind-body interventions such as mindfulness, breathing exercises, clinical hypnosis, biofeedback, and cognitive behavioral therapy may help regulate autonomic function, improve resilience, and reduce symptom burden—not because the illness is psychological, but because the nervous, immune, and endocrine systems are deeply interconnected.
Looking Ahead
Long COVID reminds us that medicine is often most challenging when diseases refuse to fit neatly into organ-based categories. Increasingly, the evidence suggests that this condition represents a complex interaction among immune dysregulation, autonomic dysfunction, mitochondrial impairment, endothelial injury, neuroinflammation, and psychosocial stressors. No single therapy is likely to address every patient’s needs.
For integrative pediatricians, this complexity should feel familiar rather than discouraging. Our discipline has long emphasized individualized care, systems biology, lifestyle optimization, and the body’s innate capacity for healing. While larger pediatric trials are urgently needed to define the role of emerging pharmacologic and nutraceutical therapies, current evidence supports a thoughtful, multidisciplinary approach that combines conventional symptom management with evidence-informed lifestyle interventions, careful attention to autonomic and mitochondrial health, and compassionate support for the emotional challenges these children and families face. In doing so, we are well positioned to help children navigate one of the most complex chronic conditions to emerge from the COVID-19 pandemic.
References
- Caliman-Sturdza OA, et al. Management of Long COVID-19 in Children and Adolescents: From Diagnosis to Therapeutically Approaches. Ann Med. 2026.
- Toepfner N, et. al. Long COVID in pediatrics–epidemiology, diagnosis, and management. European Journal of Pediatrics. 2024;183:1543-1553.
- Livieratos A, Gogos C, Akinosoglou K. Beyond antivirals: alternative therapies for Long COVID. Viruses. 2024;16:1795.
There is so much overlap between long COVID and PANDAS/PANS, and I do often wonder if I am actually treating long COVID in many of my P/P patients. The good thing is that the treatments are the same (LM, pacing, Omegas, anti-inflammatory nourishment, LDN, Vitamin D) because the mechanism is similar.